Home › Therapeutic areas › Metabolic › Type 2 Diabetes
Type 2 Diabetes (8 companies)
Companies with an active program in Type 2 Diabetes.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| BLTE | Belite Bio | MetabolicOphthalmology Rare | 1 | NDA Submitted | 6 |
| BMEA | Biomea Fusion | MetabolicOncology | 1 | Phase 2 | 4 |
| GUTS | Fractyl Health | Metabolic | 1 | Phase 3 | 3 |
| KURA | Kura Oncology | MetabolicOncology | 1 | Approved | 12 |
| NAMS | NewAmsterdam Pharma | CardiovascularMetabolic+1 | 1 | NDA Submitted | 6 |
| GPCR | Structure Therapeutics | MetabolicRespiratory Rare | 1 | Phase 3 | 5 |
| VKTX | Viking Therapeutics | MetabolicNeurology Rare | 1 | Phase 3 | 8 |
| VTVT | vTv Therapeutics | MetabolicRespiratory Rare | 2 | Phase 3 | 8 |
No companies match.